by emma
2. November 2011 12:00
Teva UK has appointed Richard Daniell as its new Managing Director.
The former commercial operations officer succeeds Dipankar Bhattacharjee, who has been promoted to a wider European role, after more than two decades working with the Teva group.
Mr Daniell says he is “excited about driving the future and vision of Teva in the UK”.
Before being appointed commercial operations officer in 2009, the new MD served as a senior director at Teva UK after serving as director of generics at IVAX Pharmaceuticals UK.
“We want to keep growing, and keep serving our customers well, and I’m confident we can do both of those things with the talented people we have in our team,” said Mr Daniell.
“I’m delighted to be leading such a forward-thinking organisation and I’m proud to be at the helm of one of the UK’s leading pharmaceutical companies.”
9d79e7c6-c72a-4d2a-8467-c1647fa449b7|0|.0
Tags: MD, Managing Director, Teva, Teva UK, Richard Daniell, Dipankar Bhattacharjee, Teva group, commercial operations officer, UK, senior director, generics, IVAX pharmaceuticals UK, pharma, pharmaceuticals, drugs, medicine, medication, treatment, therapy, pharmaceutical companies, organisation
Appointments